Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers
Cannabis Law Report
JULY 28, 2021
The results also provide confidence in the Company’s plan to dedicate resources to advance PD-001 through FDA IND-enabling studies to support Phase 1 and 2 clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer. ” Next Steps.
Let's personalize your content